MIRA Pharmaceuticals, Inc. (MIRA) Operating cash flow 2022–2025
MIRA Pharmaceuticals, Inc. (MIRA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.7MFY2025 · since FY2022: -$5.6M → -$4.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.7M | +16.2% |
| FY2024 | -$5.6M | -22.7% |
| FY2023 | -$4.5M | +19.1% |
| FY2022 | -$5.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice